First 34 amino acids of human growth hormone — retains the lipolytic and anabolic properties of full-length GH without the diabetogenic effects. Discovered by C.H. Li in the 1970s. Does not significantly raise IGF-1 levels, making it safer for long-term use.
Retains the lipolytic and anabolic domain of GH (helix 1 region). Binds GH receptor → activates lipolysis and protein synthesis pathways without significant IGF-1 elevation. No diabetogenic effect.
100-300mcg subQ 1-2x daily. Often stacked with GHRPs for enhanced GH pulse.
Refrigerate 2-8°C. Reconstitute with bacteriostatic water.